HBV-IN-22

Modify Date: 2024-01-13 20:08:27

HBV-IN-22 structure	Common Name	HBV-IN-22
	CAS Number	2338573-94-5	Molecular Weight	479.66
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₆H₂₉N₃O₂S₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of HBV-IN-22

HBV-IN-22 (Compound LC5f) is an inhibitor of HBV DNA replication with IC50 values of 0.71 µM and 0.84 µM against wild-type and drug resistant HBV strains, respectively[1].

Name	HBV-IN-22

Description	HBV-IN-22 (Compound LC5f) is an inhibitor of HBV DNA replication with IC50 values of 0.71 µM and 0.84 µM against wild-type and drug resistant HBV strains, respectively[1].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> HBV Signaling Pathways >> Cell Cycle/DNA Damage >> DNA/RNA Synthesis
Target	IC50: 0.71 µM (wild-type HBV DNA replication), 0.84 µM (drug resistant HBV DNA replication)[1]
References	[1]. Qiu J, et al. Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents. Eur J Med Chem. 2020 Nov 1;205:112581.

Molecular Formula	C₂₆H₂₉N₃O₂S₂
Molecular Weight	479.66